Article
The "pro-drug" RibCys decreases the mutagenicity of high-LET radiation in cultured mammalian cells.
Radiation research - 1 Nov 2003
Lenarczyk M, Ueno A, Vannais D B, Kraemer S, Kronenberg A, Roberts J C, Tatsumi K, Hei T K, Waldren C A
Abstract excerpt
We are carrying out studies aimed at reducing the mutagenic effects of high-LET 56Fe ions and 12C ions (56Fe ions, 143 keV/microm; 12C ions, 100 keV/microm) with certain drugs, including RibCys [2-(R,S)-D-ribo-(1',2',3',4'-tetrahydroxybutyl)-thiazolidine-4(R)-carboxylic acid]. RibCys, formed by c...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
